Key Insights

Highlights

Success Rate

79% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

13.3%

6 terminated out of 45 trials

Success Rate

78.6%

-7.9% vs benchmark

Late-Stage Pipeline

18%

8 trials in Phase 3/4

Results Transparency

45%

10 of 22 completed with results

Key Signals

10 with results79% success

Data Visualizations

Phase Distribution

36Total
Not Applicable (9)
Early P 1 (2)
P 1 (3)
P 2 (14)
P 3 (5)
P 4 (3)

Trial Status

Completed22
Terminated6
Recruiting5
Unknown5
Withdrawn3
Not Yet Recruiting2

Trial Success Rate

78.6%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (45)

Showing 20 of 20 trials
NCT05812339Enrolling By Invitation

Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls

NCT03176927Early Phase 1Completed

Biomagnetic Characterization of Gastric Dysrhythmias III

NCT07324785RecruitingPrimary

Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis

NCT04661215Recruiting

Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms

NCT05832151Phase 2CompletedPrimary

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

NCT04254549Phase 2Terminated

Rifaximin in Patients With Diabetic Gastroparesis

NCT06340217Not ApplicableRecruitingPrimary

Washed Microbiota Transplantation for Diabetic Gastroparesis

NCT05273788Phase 1RecruitingPrimary

Thoracic Neuromodulation for Diabetic Gastroparesis

NCT04303195Phase 2CompletedPrimary

A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis

NCT04474990Unknown

Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis

NCT04028492Phase 3Completed

Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

NCT06836557Phase 3Recruiting

Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

NCT04706832Early Phase 1CompletedPrimary

Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study

NCT03342157Phase 2TerminatedPrimary

Docusate/Senna for the Treatment of Diabetic Gastroparesis

NCT03680859Completed

Gastroparesis Registry 3

NCT06340828Not ApplicableNot Yet RecruitingPrimary

Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study

NCT05935852Not ApplicableUnknownPrimary

Contrast-enhanced Multispectral Optoacoustic Tomography for Non-invasive Assessment of Diabetic Gastroparesis

NCT05584462Not Yet RecruitingPrimary

Gastroparesis in type2 Diabetic Patient

NCT03544229Phase 2CompletedPrimary

A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis

NCT01696747Completed

Gastroparesis Registry 2

Scroll to load more

Research Network

Activity Timeline